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ABSTRACT 30 
 31 
Objectives: To identify subgroups of community-dwelling older-adults and to assess their 32 
longitudinal association with long-term osteoarthritis(OA) outcomes. 33 
 34 
Methods: 1046 older-adults aged 50–80 years were studied. At baseline, body mass index 35 
(BMI), pedometer-measured ambulatory activity(AA), Western Ontario and McMaster 36 
Universities Osteoarthritis Index(WOMAC) determined knee pain and information on 37 
comorbidities were obtained. Tibial cartilage volume and bone-marrow lesions(BMLs) were 38 
assessed using MRI at baseline and 10 years and total knee replacements(TKR) by data linkage 39 
to the Australian Orthopaedic Association National Joint Replacement Registry. Latent class 40 
analysis was used to determine participant subgroups, considering baseline BMI, AA, pain and 41 
comorbidities and linear mixed-effects or log-binomial models were used to assess the 42 
associations. 43 
 44 
Results: Three subgroups/classes were identified: subgroup 1 (43%): Normal/overweight 45 
participants with higher AA, lower pain and lower comorbidities; subgroup 2 (32%): 46 
Overweight participants with lower AA, mild pain and higher comorbidities; subgroup 3 47 
(25%): Obese participants with lower AA, mild pain and higher comorbidities. Subgroup 3 had 48 
greater cartilage volume loss (β:-60.56mm3, 95%CI:-105.91,-15.21) and a higher risk of TKR 49 
(RR:3.19, 95%CI:1.75,5.81), compared to subgroup 1. Subgroup 2 was not associated with 50 
cartilage volume change (β:13.06mm3, 95%CI:-30.87,57.00) or risk of TKR (RR:1.16, 51 
95%CI:0.56,2.36), compared to subgroup 1. Subgroup membership was not associated with 52 
worsening BMLs. 53 
 54 
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Conclusions: Our findings suggest the existence of homogeneous subgroups of participants 55 
and support the utility of identifying patterns of characteristics/risk factors that may cluster 56 
together and using them to identify subgroups of people who may be at a higher risk of 57 
developing and/or progressing OA. 58 
 59 
Keywords: osteoarthritis, latent-class analysis, cartilage volume, bone-marrow lesions, total 60 
knee replacement. 61 
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Key messages 63 
 64 
• Complex interplay among characteristics/factors leads to conflicting evidence between 65 
ambulatory activity and knee osteoarthritis. 66 
 67 
• Distinct subgroups are identifiable based on ambulatory activity, body mass index, knee 68 
pain and comorbidities. 69 
 70 
• Identifying subgroups can be used to determine those who are at risk of 71 
developing/progressing osteoarthritis. 72 
  73 
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INTRODUCTION 74 
 75 
Knee Osteoarthritis (OA) is a complex disease with multiple contributing factors[1]. The rates 76 
of incident knee OA and the need for total knee replacements (TKR) have been increasing 77 
steadily[2]. Hence, identification of characteristics/risk factors for the onset and progression of 78 
knee OA will aid in designing better preventative and management strategies. 79 
 80 
Traditionally, epidemiological studies have investigated individual characteristics/risk factors 81 
in isolation, and their associations with knee OA[3, 4]. While there have been clear associations 82 
identified between some factors such as obesity and knee OA[5], the association of ambulatory 83 
activity (AA) with knee OA has been conflicting[6]. One important reason for this 84 
inconsistency could be the heterogeneity of the population characteristics and the complex 85 
interplay between characteristics[7]. Hence, acknowledging the existence of certain patterns of 86 
characteristics/risk factors leading to subgrouping may help to improve the overall 87 
understanding of OA[8, 9]. Accordingly, it may prove more valuable to examine AA as one 88 
characteristic that clusters with other characteristics[10]; i.e. to identify relatively homogenous 89 
subgroups of participants with similar characteristics which includes AA and to examine the 90 
relationship between the subgroups and OA outcomes. 91 
 92 
Identification of such subgroups can relay important information on the aetiology of the 93 
disease[11] and will assist in designing better preventative strategies[12]. In identifying 94 
subgroups, it is further important to consider modifiable characteristics rather than non-95 
modifiable characteristics (e.g.: age, sex) in order to improve the usefulness of classification in 96 
clinical practice and in epidemiological studies[9, 13]. Factors/characteristics such as body 97 
mass index (BMI)[14] and comorbidities[15] are suggested to be correlated with AA in older-98 
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adults. In addition to these factors/characteristics, pain in OA may also affect the AA levels in 99 
people as the AA levels may be adjusted in order to reduce the pain experienced[10, 16, 17]. 100 
Hence, these modifiable factors could be useful in identifying naturally occurring subgroups 101 
in populations. 102 
 103 
We therefore hypothesized that there are distinct subgroups of participants with similar 104 
characteristics, based on AA, knee pain, BMI and comorbidities which are associated with the 105 
onset and progression of knee OA. The objectives of this study, thus, were to identify 106 
subgroups of individuals using a multi-dimensional approach and to investigate the 107 
longitudinal association of these subgroups with tibial cartilage volume change, worsening 108 
bone-marrow lesions (BMLs) and TKR in a population of community-dwelling older-adults. 109 
  110 
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MATERIALS AND METHODS 111 
 112 
Study population 113 
 114 
This study was based on Tasmanian Older Adult Cohort Study (TASOAC). TASOAC is a 115 
prospective population-based study aimed at examining the incidence and progression of OA. 116 
The participants between 50-80 years were randomly selected with an equal number of men 117 
and women from the community in Southern Tasmania (population 229,000) using the 118 
electoral roll. Electoral rolls represent the most complete population information available in 119 
Australia because voting is compulsory in federal and state elections. The sample was stratified 120 
by sex to provide equal numbers of men and women, and equal distribution was drawn from 121 
urban and rural areas. As TASOAC was designed to examine community-dwelling older 122 
adults, institutionalised older adults were excluded. Participants were also excluded if they had 123 
contraindications to Magnetic Resonance Imaging (MRI). Data collection was undertaken at 124 
baseline (n=1099) between March 2002 and September 2004 and at 10 years. Of the initially 125 
eligible participants contacted (1,904), 1,099 were enrolled in the study (57% response rate). 126 
The research was conducted in compliance with the Helsinki Declaration. Ethical approval was 127 
granted by the Southern Tasmanian Health and Medical Human Research Ethics Committee. 128 
Written informed consent was obtained from all participants.  129 
 130 
Magnetic Resonance Imaging 131 
 132 
A 1.5T MRI of the right knee was performed at baseline and 10 years, in the sagittal plane on 133 
a Picker apparatus (Ohio, USA) and a Siemens apparatus (Espree, Pennsylvania, USA). The 134 
image sequence is explained elsewhere[18]. Briefly: (1) T1-weighted fat saturation three–135 
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dimensional gradient-recalled acquisition in the steady state, (2) T2-weighted fat saturation 136 
two-dimensional fast spin echo. 137 
 138 
Cartilage volume (mm3) 139 
 140 
A trained reader assessed the cartilage volume on T1-weighted MRIs using OsiriX software 141 
(University of Geneva, Geneva, Switzerland)[19]. The coefficient of variation for intra-142 
observer repeatability ranged from 2.1–2.2%[19]. Medial tibial and lateral tibial cartilage 143 
volumes were measured. Total tibial cartilage volume was calculated as medial + lateral tibial 144 
cartilage volumes. 145 
 146 
Cartilage volume measurements were conducted with the baseline and 10-year MRIs paired, 147 
with the chronological order known for participants who had MRIs at both baseline and 10-148 
year follow-up (n=481) (Figure 1). 149 
 150 
Bone-Marrow Lesions (mm2) 151 
 152 
Subchondral BMLs were assessed on T2-weighted MRIs using OsiriX software at medial and 153 
lateral sites of tibia and femur. BMLs were defined as areas of increased signal intensity on 154 
T2-weighted images, located immediately under the articular cartilage. One trained observer 155 
read the BMLs with the images paired and the chronological order known, by measuring the 156 
maximum area of the lesion at each site at baseline (n=661) and 10-year follow-up (n=496) 157 
(Figure 1). Intra-observer reliability was excellent (0.98 (95% CI; 0.96, 0.99)). 158 
 159 
Primary total knee replacement  160 
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 161 
Incident primary (first-time) TKR was determined by data linkage to the Australian 162 
Orthopaedic Association National Joint Replacement Registry (AOANJRR), between 1 March 163 
2002 and 21 September 2016. AOANJRR collects data from both public and private 164 
hospitals[20] in Tasmania. Matched data obtained from AOANJRR included the date and side 165 
of TKR, primary or revision TKR and the reason for TKR (e.g.: OA)[7]. In this cohort, there 166 
were 3 uni-compartmental knee replacements (Figure 1). 167 
 168 
Ambulatory activity 169 
 170 
AA was determined as steps/day using pedometers (Omron HJ–003 & HJ-102, Omron 171 
Healthcare, Kyoto, Japan), at baseline. The participants were informed on pedometer use, 172 
keeping a log/diary of step-count and the time during which those were worn. They were 173 
required to wear the pedometers for seven consecutive days as they conducted day-to-day 174 
activities except during water activities and sleeping. This was repeated after six months in 175 
order to account for habitual changes in different seasons. Therefore, 2 sets of logs were 176 
available per participant. Readings were screened and excluded if there was any evidence of 177 
artificial pedometer readings. Then, pedometer wear-time was determined for each day 178 
utilizing the pedometer logs. A ‘valid pedometer wear-day’ was considered as a day on which 179 
the pedometer was worn for at least 8 hours. Then, the steps/day count was calculated as the 180 
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Weight was measured to the nearest 0.1 kg using electronic scales (Heine, Dover, New 185 
Hampshire, USA). Height was measured to the nearest 0.1 cm using a Leicester stadiometer 186 
(Invicta, Leicester, UK). BMI (kg/m2) was calculated. 187 
 188 
Knee pain 189 
 190 
Knee pain was assessed using the Western Ontario and McMaster Universities Osteoarthritis 191 
Index (WOMAC)[21] which consists of five subscales, each scored on a 10-point scale ranging 192 
from 0 (no pain) to 9 (most severe pain). A total WOMAC pain score was calculated by 193 




Self-reported prevalence of common comorbidities including musculoskeletal (osteoporosis, 198 
rheumatoid arthritis), cardio-respiratory (heart attacks, hypertension, thrombosis, diabetes, 199 
asthma, bronchitis/emphysema), and other medical conditions (hyperthyroidism, 200 
hypothyroidism, other major medical conditions) were collected. 201 
 202 
Other covariates 203 
 204 
Information on age, smoking and alcohol consumption were collected at baseline. The 205 
participants’ socio-economic status was determined by the Socio-Economic Indexes for Areas 206 
(SEIFA) defined by Australian Bureau of Statistics. History of knee injury was assessed at 2.5-207 
year follow-up. Knee x-rays were performed at baseline for all participants and scored for 208 
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osteophytes and joint space narrowing[22] and prevalence of radiographic OA (ROA) was 209 
defined. 210 
 211 
Statistical analysis 212 
 213 
Latent class analysis (LCA) was used to identify subgroups of participants with similar 214 
characteristics considering baseline AA, WOMAC pain, BMI and prevalence of comorbidities. 215 
Using the variables, LCA determines the least number of meaningful classes with minimized 216 
within-class and maximised between-class variation and calculates the likelihood of each 217 
participant being allocated to a class[23]. 218 
 219 
In order to identify the optimum number of classes that meaningfully group participants with 220 
similar characteristics, several model fit statistics including log-likelihood (LL), Akaike 221 
information criterion (AIC) and Bayesian information criterion (BIC) were used in 222 
combination[24]. Then a model with higher LL and lower AIC, BIC was identified. 223 
Additionally, the overall model interpretability was considered in identifying the number of 224 
classes[25, 26]. Furthermore, predictions of the maximum posterior probability of class 225 
membership were used to evaluate an individual’s probability of being in each class[25]. 226 
 227 
Baseline characteristics of the population by subgroups were described as means and standard 228 
deviations or as percentages as appropriate. 229 
 230 
The association between the subgroups and the 10-year cartilage volume change was estimated 231 
using linear mixed-effects models. The model included fixed-effects terms for time (years), 232 
subgroup, and a subgroup by time interaction. The interaction term estimates the cartilage 233 
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volume change per year over the period for each subgroup compared to the reference group 234 
(subgroup 1). A random intercept was specified for each participant to account for baseline 235 
individual differences. 236 
 237 
Log-binomial regression was used to estimate the association between the subgroups and 238 
worsening BMLs which was defined as the incidence of a deleterious change in BML area 239 
representing a genuine change of BMLs. A deleterious change in BMLs was determined as an 240 
increase of BML size larger than the least significant criterion (52mm2); this considers the 241 
measurement error and the correlation between the BML measurements at both baseline and 242 
10-year follow-up[18, 27]. 243 
 244 
Log-binomial regression using a generalized estimating equation with log link and binomial 245 
family was used to estimate the relationship between the subgroups and risk of TKR. In order 246 
to account for the correlation between observations on the same individual (right and left legs), 247 
an exchangeable correlation structure was used adjusting for standard errors using the sandwich 248 
(robust) estimator of variance[28]. 249 
 250 
All the models were adjusted for baseline age, sex and knee injury. Since knee ROA is an 251 
important indication for TKR[29], we additionally adjusted the TKR model for baseline ROA 252 
in order to assess if the relationships were independent of ROA. Other potential confounders 253 
were considered but were not included in the final models as they did not change the relative 254 
risk (RR) or beta-coefficients by at least 10%[30]. 255 
 256 
Effect modification of cartilage volume change for subgroups was explored using 3-way 257 
interaction terms (and their respective lower order terms) with age, sex and knee injury. For 258 
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worsening BMLs and the risk of TKR, effect modification was explored using two-way 259 
interactions for subgroups with age, sex, knee injury and ROA. 260 
 261 
To address any potential bias due to missing data, we conducted sensitivity analyses using 262 
inverse probability weighting, assuming that the data were missing at random (MAR)[31, 32]. 263 
This was done under two steps; first, the probability of a participant being present at the follow-264 
up was estimated by fitting logistic regression models using baseline variables (age, sex, BMI, 265 
comorbidities, socio-economic status, AA, smoking and alcohol consumption), second, the 266 
models estimating the associations were weighted using the inverse of the estimated 267 
probabilities of being present at the follow-up. 268 
 269 
A p value less than 0.05 (two-tailed) was regarded as statistically significant. All statistical 270 
analyses were performed on Intercooled Stata V.15.1 for Mac (StataCorp LP, Texas, USA). 271 
  272 
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RESULTS 273 
 274 
The average follow-up period for cartilage volume change and BMLs was 10.7 years (±0.7), 275 
while for TKR, it was 12.1 years (±2.8). 1049 participants were included in the LCA models. 276 
 277 
Subgroup identification 278 
 279 
LCA model fit statistics were assessed for two to six classes. Although the LL was slightly 280 
higher for a two-class model, compared to a three-class model (-5578 vs. -5563), the AIC and 281 
BIC all favoured the three-class model with lower AIC and BIC, compared to two-class model 282 
(AIC, 11160 vs. 11183; BIC, 11245 vs. 11248). Between three-class and four-class models, a 283 
three-class model was favoured owing to higher LL (-5563 vs. -5560), lower AIC (11160 vs. 284 
11161) and lower BIC (11245 vs. 11261). Comparing with five- and six-class models, a three-285 
class model was favoured as the LL was higher and BIC was lower although AIC was slightly 286 
higher (Supplementary table 1). Furthermore, five- or six-class models did not suggest 287 
distinctive classes in comparison to the more parsimonious three-class model . Hence the three-288 
class model was considered as the best fit. Once the class structure was determined, the 289 
participants were allocated to the classes based on the predictions of the maximum posterior 290 
probability. The mean posterior probability for the three classes were 0.78 (±0.19), 0.75 (±0.15) 291 
and 0.70 (±0.11). 292 
 293 
Three classes/subgroups were identified: subgroup 1 (43%): Normal/overweight participants 294 
with higher AA levels, lower pain and lower prevalence of comorbidities; subgroup 2 (32%): 295 
Overweight participants with lower AA levels, mild pain and higher prevalence of 296 
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comorbidities; subgroup 3 (25%): Obese participants with lower AA levels, mild pain and 297 
higher prevalence of comorbidities. 298 
 299 
Baseline characteristics 300 
 301 
Compared to subgroup 1, participants in subgroup 2 and 3 were older, had lower AA levels, 302 
higher BMI, higher WOMAC pain (although their pain was in the mild range), a higher 303 
prevalence of comorbidities and a higher prevalence of knee ROA (Table 1). 304 
 305 
Participants with missing data were older and had lower AA levels. They were also more likely 306 
to have higher WOMAC pain and higher prevalence of comorbidities (Supplementary table 2). 307 
 308 
Association of subgroups and the change in tibial cartilage volume 309 
 310 
The mean cartilage volume loss of the population over 10 years was 465 (±231) mm3 (data not 311 
shown). On average, cartilage volume for subgroup 1 decreased by 256.70 mm3 (95% CI -312 
354.35, -159.05) over 10 years. Multivariable analyses showed that participants in subgroup 3 313 
had greater cartilage volume loss over 10 years while subgroup 2 was not associated with 314 
cartilage volume change, compared to subgroup 1 (Table 2). 315 
 316 
Association of subgroups and worsening BMLs 317 
 318 
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There were 221/489 participants with worsening BMLs over 10 years. In multivariable 319 
analyses, being in subgroup 2 or 3 was not associated with worsening BMLs, compared to 320 
subgroup 1 (Table 3). 321 
 322 
Association between subgroups with the risk of TKR 323 
 324 
There were 79/899 participants with a TKR. Multivariable analyses showed that participants 325 
in subgroup 3 had a greater risk of TKR while subgroup 2 was not associated with a risk of 326 
TKR, compared to subgroup 1 (Table 4). 327 
 328 
There was no evidence for interaction by age, sex, knee injury or ROA in any of the models. 329 
 330 
The results of the sensitivity analyses that used inverse probability weighting were similar with 331 
no changes to the inference when compared to the complete case analysis (Supplementary 332 
tables 3–5).   333 
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DISCUSSION 334 
 335 
This prospective cohort study identified subgroups of participants with similar characteristics 336 
in a population of community-dwelling older-adults and assessed the longitudinal association 337 
of these subgroups with cartilage volume change, worsening BMLs and TKR. Three subgroups 338 
were identified; subgroup 1: Normal/overweight participants with higher AA, lower pain, and 339 
lower prevalence of comorbidities; subgroup 2: Overweight participants with lower AA, mild 340 
pain and higher prevalence of comorbidities; subgroup 3: Obese participants with lower AA, 341 
mild pain and higher prevalence of comorbidities. We found that subgroup 3 participants lost 342 
more cartilage volume and were at a higher risk of TKR, while being in subgroup 2 was not 343 
associated with knee OA outcomes, compared to subgroup 1. These findings suggest the 344 
existence of subgroups of participants within a population and highlight the importance of 345 
identifying characteristic/risk factor patterns that may cluster together and using them to 346 
determine subgroups of people who may be at a higher risk of developing and progressing OA. 347 
 348 
There has been increasing interest in the field of OA research to identify clinical 349 
phenotypes/subtypes of OA, based on clinical, imaging and laboratory biomarkers[12, 25, 33-350 
35]. Individual biomarkers are not adequate in defining disease onset or progression[13]; 351 
therefore, determining clinical subtypes of OA presents advantages in accurate treatment 352 
allocation and development of new treatment strategies. It is equally important to identify 353 
subgroups of participants that may carry a higher risk for the development and progression of 354 
OA which would also be helpful to define tailored strategies to prevent or slow the disease 355 
progression[36]. To the best of our knowledge, no other studies have evaluated the existence 356 
of subgroups with relatively homogenous characteristics related to AA. Taken together, these 357 
studies further substantiate the existence of homogenous subgroups within populations and the 358 
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utility of classifying subgroups within a cohort, to better identify participants at a higher risk 359 
of OA development and progression. 360 
 361 
Interestingly, AA has been shown to be beneficial for symptomatic knee OA and is widely used 362 
as a treatment in relieving symptoms[37]. Yet, the beneficial or harmful effects of AA on 363 
structural development and progression of OA remains uncertain[3]. Hence, studying the 364 
clustered effects of AA with other characteristics/risk factors may be important and provides a 365 
novel strategy to help unravel the AA and OA debate. The healthy subgroup (subgroup 1) 366 
observed in this study with normal BMI, higher AA, lower pain and lower prevalence of 367 
comorbidities, did not appear to have an increased risk of cartilage volume loss, worsening 368 
BMLs or incident TKR, compared to other subgroups (data not shown). Hence it may be argued 369 
that, amidst other characteristics/risk factors, AA may not be a factor that contributes 370 
substantially to the increased risk of structural progression in OA. However, due to the nature 371 
of this analysis, it is difficult to separate the independent effects of AA on the outcomes, hence 372 
further studies are needed to confirm this hypothesis. 373 
 374 
In this study, subgroup 3 participants lost more cartilage volume and were at an increased risk 375 
of TKR, compared to subgroup 1. Studies have shown that obesity is associated with increased 376 
cartilage volume loss[38] and increased risk of TKR[7], owing to the increased loading and 377 
low-grade inflammation[5]. Additionally, in previous studies conducted on this cohort, authors 378 
found that AA was not related to cartilage volume loss as a main effect[3], but was associated 379 
with a small increased risk of TKR[7]. Furthermore, higher prevalence of comorbidities and 380 
higher pain may co-occur with higher BMI and lower AA, suggesting that these factors may 381 
have complex interplay which leads to early expression of the underlying disease processes 382 
related to OA. Interestingly, subgroup 3 was not related with worsening BMLs. Previous 383 
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reports have shown that BMI was not associated with worsening BMLs[18, 39, 40], while AA 384 
has been suggested to be related with an increased risk of worsening BMLs[3]. Therefore, it 385 
may be that worsening of BMLs is a result of several contributing factors. Subgroup 2 was not 386 
associated with any OA outcome. Indeed, the majority of the participants in this cohort were 387 
overweight older-adults. Although there were statistically significant differences in BMI 388 
between the subgroups 1 and 2, it was only a little higher in subgroup 2, compared to subgroup 389 
1. Hence, the smaller increase in BMI combined with other characteristics/risk factors may not 390 
contribute to the risk of long-term OA outcomes for subgroup 2. 391 
 392 
It is further important to consider why these subgroups can be defined using these variables in 393 
this cohort. Both physiological and environmental factors may play a key role in determining 394 
these subgroups. Subgroup 1 represents participants with mostly normal/overweight BMI, 395 
higher AA, lower pain and comorbidities who were younger compared to the other subgroups; 396 
hence, signifies a younger, active and healthy group. Subgroup 2 was largely comprised of 397 
overweight participants with lower AA, mild pain and higher comorbidity levels and the 398 
participants were older compared to the other subgroups. The prevalence of higher comorbidity 399 
levels, mild pain and older age may partly explain their lower AA levels[10, 15, 41, 42]. In 400 
subgroup 3, participants were mainly obese with lower AA, mild pain and higher comorbidity 401 
levels, representing a group with mechanical overloading and metabolic syndrome[34]. In line 402 
with this, a recent systematic review suggested six clinical phenotypes out of which three 403 
included a higher BMI/obesity component, characterized by inflammatory mechanisms, 404 
metabolic syndrome and mechanical overloading[11]. Furthermore, a higher prevalence of 405 
comorbidities in the subgroups 2 & 3 may be suggestive of ongoing, widespread systemic 406 
inflammation[43]. Importantly, the findings of this study may be used in clinical settings to 407 
guide treatment allocation for older-adults. Weight loss programs with increased AA/exercise, 408 
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prevention or management of comorbidities and pain may be recommended in clinical settings 409 
for people who demonstrate characteristics similar to subgroup 3. Those who express subgroup 410 
2 characteristics may benefit from weight maintenance/loss with increased AA/exercise, 411 
prevention or management of comorbidities and pain. 412 
 413 
There are a few strengths to this study that includes the long-term follow-up, community-based 414 
cohort, large sample size, inclusion of objectively measured and validated exposure (AA, BMI 415 
and pain) and outcome (cartilage volume, BMLs, TKR) measures. This study used an LCA 416 
approach to define subgroups where methods such as LCA or cluster analysis are more reliable, 417 
less subjective and appropriate methods in defining naturally occurring subgroups in a 418 
population[13, 44]. However, there are a few limitations to this study. First, while LCA is a 419 
suggested method, it largely depends on the choice of variables. Yet, in this analysis, we have 420 
mostly used objective and standardized variables to define subgroups. Second, there can be 421 
differences in AA participation in different ethnic groups[45]. This cohort was largely 422 
comprised of Caucasians, therefore, these subgroups may not be directly applicable to other 423 
populations, which hinders the generalizability. Hence, further studies exploring the subgroups 424 
in other populations/ethnic groups are warranted. Third, in this study, subgrouping was only 425 
performed at baseline, and potential temporal changes of the characteristics and their 426 
implications were not assessed. Fourth, we have only considered activity during ambulation, 427 
and have not considered the intensity or nature of the activity, due to the lack of information. 428 
Fifth, there were missing data in the analyses, and the participants with missing data were older 429 
and had lower AA levels. However, in the sensitivity analyses, we observed that, although the 430 
effect sizes were slightly different, the inference was not changed when compared to the 431 
complete case analysis. This suggests that there was no bias introduced to the final results of 432 
the complete case analysis by the missing data.  433 
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 434 
In summary, the findings of this study suggest the existence of homogeneous subgroups of 435 
participants and support the utility of identifying patterns of characteristics/risk factors that 436 
may cluster together and using them to identify subgroups of people who may be at a higher 437 
risk of developing and/or progressing OA.  438 
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BMI – body mass index, WOMAC - Western Ontario McMaster Osteoarthritis Index, BML – bone marrow lesions, TKR – total knee 625 
replacement.  626 
Attend clinic at Phase 1 (n=1099) 
 
Exposures 
-Physical activity (n = 1049) 
-BMI (n = 1099) 
-Comorbidities (n = 1075) 
-WOMAC pain (n = 1096) 
 
Outcomes 
-Cartilage volume measures (n = 481) 
-BML measures (n = 661) 
-Prior TKR at baseline (n=4)  
 
Participants attended 






-BML measures (n=496) 
(n=7 did not have 
baseline BML measure) 
 
Included in unadjusted 
TKR analysis over 12 
years (n =899) 
Lost to follow-up 
-Deceased before TKR (n = 182) 
-Moved overseas (n = 14) 
Lost to follow-up 
-Deceased (n = 150) 
-Moved interstate or overseas (n = 47) 
-Refused to continue (n = 131) 
-Other reasons (n= 203) 
Included in unadjusted 
analyses 
-Cartilage volume (n=481) 
-BML (n = 489) 
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Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age (years) 60.9 (6.7) 65.8 (7.7) 62.7 (7.1) 62.9 (7.4) 
Sex (Female: %) 49  49  57  51  
Ambulatory activity (steps/day) 10,780 (3,006) 6,879 (2,343) 7,117 (2,891) 8,615 (3,355) 
BMI (kg/m2)  25.5 (3.0) 26.1  (2.5) 34.1 (3.7) 27.8 (4.7) 
BMI categories         
   Normal/Underweight (%) 44  30  0  29  
   Overweight (%) 50  70  0  44  
   Obese I (%) 6  0  69  19  
   Obese II & above (%) 0  0  31  8  
WOMAC pain 2.1 (4.2) 4 (6.0) 5.8 (8.0) 3.6 (6.1) 
Comorbidities (%) 49  96  86  73  
Knee ROA (%) 55  63  66  60  
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BMI – body mass index, WOMAC - Western Ontario McMaster Osteoarthritis Index, ROA - Radiographic osteoarthritis. 643 
Significant between-group differences shown in bold. 644 
 
 Page 34 
Table 2 Association between subgroups and the cartilage volume change over 10 years 645 
†Adjusted for age, sex and history of knee injury. Significant results shown in bold, *β-646 
coefficient represents the difference in cartilage volume change for each subgroup compared 647 
to subgroup 1, over 10 years.  648 
 
Unadjusted (n=481) †Adjusted (n=481) 
*β  (95% CI) *β (95% CI) 
        
Mean change for subgroup 1 
over 10 years (mm3) 
-414.96 (-439.32  -390.60) -256.70 (-354.35,  -159.05) 
        
Change in cartilage volume 
for each subgroup over 10 
years* 
      
Subgroup 1 (n = 259)  Ref   Ref    
Subgroup 2 (n = 116) 13.21 (-30.84, 57.25) 13.06 (-30.87, 57.00) 
Subgroup 3 (n = 106) -66.46 (-111.79, -21.13) -60.56 (-105.91, -15.21) 
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Table 3 Association between subgroups with worsening bone-marrow lesions over 10 years 649 
†Adjusted for age, sex and history of knee injury.  650 
 
Unadjusted (n=489) †Adjusted (n=488) 
RR  (95% CI) RR (95% CI) 
       
Subgroup 1 (n = 257)  Ref   Ref    
Subgroup 2 (n = 124) 0.91 (0.71, 1.16) 0.93 (0.72, 1.19) 
Subgroup 3 (n = 108) 0.99 (0.78, 1.27) 1.02 (0.80, 1.30) 
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Table 4 Association between subgroups with the risk of total knee replacements over 12 651 
years 652 
†Adjusted for age, sex, history of knee injury and knee radiographic OA. Significant results 653 
are shown in bold. 654 
 
Unadjusted (n=899) †Adjusted (n=687) 
RR  (95% CI) RR (95% CI) 
       
Subgroup 1 (n = 417)  Ref   Ref    
Subgroup 2 (n = 260) 1.17 (0.64, 2.15) 1.16 (0.56, 2.36) 
Subgroup 3 (n = 222) 2.77 (1.67, 4.58) 3.19 (1.75, 5.81) 
